Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041739 | SCV000065435 | likely pathogenic | Rare genetic deafness | 2009-05-06 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV001073672 | SCV001239225 | pathogenic | Retinal dystrophy | 2019-08-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002514159 | SCV003523480 | pathogenic | not provided | 2022-06-22 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 48416). This premature translational stop signal has been observed in individual(s) with Usher syndrome (PMID: 24944099). This variant is present in population databases (rs111033417, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Trp4438*) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). |
Genome- |
RCV003450773 | SCV004181886 | likely pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003450773 | SCV004208353 | pathogenic | Retinitis pigmentosa 39 | 2023-12-14 | criteria provided, single submitter | clinical testing |